MLRKX
Price
$27.55
Change
-$0.18 (-0.65%)
Updated
Jul 16 closing price
Net Assets
3.94B
VSMPX
Price
$338.46
Change
-$1.65 (-0.49%)
Updated
Jul 16 closing price
Net Assets
2.3T
Interact to see
Advertisement

MLRKX vs VSMPX

MLRKX vs VSMPX Comparison Chart in %
View a ticker or compare two or three
VS
MLRKX vs. VSMPX commentary
Jul 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLRKX is a Hold and VSMPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 2.3T vs. MLRKX (3.94B). VSMPX pays higher dividends than MLRKX: VSMPX (1.06) vs MLRKX (0.56). MLRKX was incepted earlier than VSMPX: MLRKX (8 years) vs VSMPX (11 years). MLRKX (0.51) is less costly to investors than VSMPX (0.02). MLRKX is a more actively managed with annual turnover of: 117.00 vs. VSMPX (3.00). MLRKX has a lower initial minimum investment than VSMPX: MLRKX (5000000) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 21.29 vs. MLRKX (19.26). VSMPX return over 5 years is better than : 68.20 vs. MLRKX (23.98).
MLRKXVSMPXMLRKX / VSMPX
Total Expense Ratio0.430.022,150%
Annual Report Gross Expense Ratio0.510.022,550%
Fund Existence8 years11 years-
Gain YTD14.44511.121130%
Front LoadN/AN/A-
Min. Initial Investment50000001000000005%
Min. Initial Investment IRAN/AN/A-
Net Assets3.94B2.3T0%
Annual Yield % from dividends0.561.0653%
Returns for 1 year19.2621.2990%
Returns for 3 years49.9866.1276%
Returns for 5 years23.9868.2035%
Returns for 10 yearsN/A238.37-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSHAX13.060.13
+1.01%
NYLI Cushing® MLP Premier Class A
CEMIX18.23N/A
N/A
Causeway Emerging Markets Instl
GABEX5.21N/A
N/A
Gabelli Equity Income AAA
TRAIX38.41N/A
N/A
T. Rowe Price Capital Appreciation I
MCYIX16.49-0.29
-1.73%
NYLI Candriam Emerging Markets Eq Cl I